CellCarta offers the Meso Scale Discovery® (MSD) platform for multiplexed, high-sensitivity, quantitative assays. MSD® technology builds on well-established assay formats, leveraging electrochemiluminescent (ECL) detection which offers distinct advantages over standard ELISAs. Multiplexing allows the measurement of up to ten analytes in each well of a 96-well plate using serum or plasma samples as small as 25 μL.